Title:
5-HT4 RECEPTOR AGONIST FOR GASTROPARESIS
Document Type and Number:
WIPO Patent Application WO/2015/174098
Kind Code:
A1
Abstract:
This invention relates to 4-{[4-({[4-(2,2,2-trifluoroethoxy)-1,2-benzisoxazol-3-yl]-oxy}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid for use in therapeutic treatment of the human body. In particular, it relates to the compound having selective 5-HT4 receptor agonism, which is useful for treating gastroparesis, or preventing or delaying the onset or the progression of gastroparesis.
Inventors:
TAKAHASHI NOBUYUKI (JP)
YAMAMOTO TOSHINORI (JP)
SHIMADA KAORU (JP)
NOGUCHI HIROHIDE (JP)
YAMAMOTO TOSHINORI (JP)
SHIMADA KAORU (JP)
NOGUCHI HIROHIDE (JP)
Application Number:
PCT/JP2015/002478
Publication Date:
November 19, 2015
Filing Date:
May 18, 2015
Export Citation:
Assignee:
RAQUALIA PHARMA INC (JP)
International Classes:
A61K31/454; A61P1/04; A61P3/10; A61P5/14; A61P17/00; A61P25/00; A61P25/06; A61P25/16; A61P31/12
Domestic Patent References:
| WO2006090224A1 | 2006-08-31 | |||
| WO2012127878A1 | 2012-09-27 |
Foreign References:
| US20050090554A1 | 2005-04-28 | |||
| US20030059374A1 | 2003-03-27 |
Other References:
EXPERT OPIN. PHARMACOTHER., vol. 1, no. 5, 2000, pages 881 - 887, XP055430714
NEUROGASTROENTEROL. MOTIL., vol. 20, 2008, pages 99 - 112, XP055360934
EXPERT OPIN. INVESTIG. DRUGS, vol. 19, no. 6, 2010, pages 765 - 775, XP055360938
See also references of EP 3142666A4
NEUROGASTROENTEROL. MOTIL., vol. 20, 2008, pages 99 - 112, XP055360934
EXPERT OPIN. INVESTIG. DRUGS, vol. 19, no. 6, 2010, pages 765 - 775, XP055360938
See also references of EP 3142666A4
Attorney, Agent or Firm:
IWATANI, Ryo (1-31 Dojima 2-chome, Kita-ku, Osaka-sh, Osaka 03, JP)
Download PDF:
Previous Patent: PLATING SOLUTION FOR SCREWED PIPE JOINT AND PROCESS FOR PRODUCING SCREWED PIPE JOINT
Next Patent: MEMORY SYSTEM
Next Patent: MEMORY SYSTEM